SCHEMBL202184

SCHEMBL202184

[CH2]CC([CH2])OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8996097 0.73
SCHEMBL8087935 0.71
SCHEMBL19323 0.71
SCHEMBL491421 0.69
SCHEMBL1030243 0.69
SCHEMBL11783822 0.69
SCHEMBL1829963 0.69
SCHEMBL910847 0.69
SCHEMBL4276846 0.69
SCHEMBL9512598 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861878-B1 Unsymmetrical perylene dimers XEROX CORP (US) 2001-10-24 EP claimed
EP-0861878-A1 Unsymmetrical perylene dimers XEROX CORPORATION (US) 1998-09-02 EP claimed
US-5683842-A CHARGE GENERATORS FOR IMAGES XEROX CORPORATION (US) 1997-11-04 US claimed
JP-8310996-A None JP disclosed
JP-8104724-A None JP disclosed
US-9943498-B2 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias VIFOR (INTERNATIONAL) AG (CH) 2018-04-17 US disclosed
EP-2549991-B1 FE(III) COMPLEX COMPOUNDS FOR TREATING AND PROPHYLAXIS FOR ANAEMIA SYMPTOMS AND ANAEMIA VIFOR (INTERNATIONAL) AG (CH) 2017-11-22 EP disclosed
EP-1603414-B1 ELECTROPROCESSED PHENOLIC MATERIALS AND METHODS UNIV VIRGINIA COMMONWEALTH (US) 2017-05-03 EP disclosed
US-20160310459-A1 Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias VIFOR (INTERNATIONAL) AG (CH) 2016-10-27 US disclosed
US-9394324-B2 Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias VIFOR (INTERNATIONAL) AG (CH) 2016-07-19 US disclosed
EP-2120965-B1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES NOVABAY PHARMACEUTICALS INC (US) 2014-11-05 EP disclosed
EP-0742211-A1 PYRIDAZINONE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1996-11-13 EP disclosed
JP-H08104724-A PRODUCTION OF URETHANE PREPOLYMER THAT REMAINS LIQUID EVEN AT LOW TEMPERATURE HODOGAYA CHEM CO LTD 1996-04-23 JP disclosed
EP-0282419-B1 Ether free organometallic amide compositions LITHIUM CORP (US) 1995-04-05 EP disclosed
EP-0465369-B1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL UCLAF (FR) 1994-04-13 EP disclosed
US-5300252-A Ether free organometallic amide compositions FMC CORPORATION (US) 1994-04-05 US disclosed
US-5190974-A Analgesics ROUSSEL UCLAF (FR) 1993-03-02 US disclosed
EP-0506087-A2 Cleaning compositions and methods for using same UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (a New York corporation) (US) 1992-09-30 EP disclosed
EP-0465369-A1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1992-01-08 EP disclosed
US-4944894-A Ether free organometallic amide compositions LITHIUM CORPORATOIN OF AMERICA (US) 1990-07-31 US disclosed